Our
Organoid Lab provides a platform to test FDA-approved drugs on PDO for personalised
therapy, and small-molecules chemical screen of new compounds.
Patient-derived colorectal cancer (CRC) organoid
Sensitivity to MEK inhibitor Trametinib
Resistance to mTOR inhibitor (Everolimus) and PI3K inhibitor (Alpelisib)